Reliance ADAG Group Chairman Anil Ambani skipped the Enforcement Directorate’s (ED) summons for the second time, failing to appear before the agency ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Myelofibrosis Market Size is ...

The 2025 Market Dynamix™: Psoriatic Arthritis and Ankylosing Spondylitis/Non-Radiographic Axial Spondyloarthritis (EU5) studies from Spherix Global Insights reveal a rapidly evolving treatment ...

A systematic review reports that monoclonal antibodies and JAK inhibitors can be effective in the treatment and clearance of ...

Abivax delivered outstanding phase 3 results for obefazimod in ulcerative colitis, with a 16.4% placebo-adjusted clinical remission rate. See why ABVX stock is a Buy.

American driver Jak Crawford will be Aston Martin's third driver for the 2026 Formula 1 season, effectively acting as reserve to Fernando Alonso and Lance Stroll should either be unable to race.

American youngster Jak Crawford has inched closer to a Formula 1 drive by stepping up to the role of Aston Martin’s reserve driver. Crawford, 20, joined Aston Martin’s young driver development program ...

Aston Martin has announced that American Formula 2 star Jak Crawford will be the team's third driver for the 2026 Formula 1 season. Crawford will continue the development role he has taken as part of ...

AUSTIN -- Rising American racing star Jak Crawford will drive in first practice for Aston Martin ahead of Formula 1's Mexico City Grand Prix next week. Crawford, 20, will take Lance Stroll's seat in ...

The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for cases where a patient may not be appropriate for a TNF blocker, drugmaker ...